first drug for orthostatic hypotension, ProAmatin (midodrine)
October 1996
The FDA just approved the first drug for orthostatic hypotension, ProAmatine (midodrine). It received accelerated approval...similar to important new drugs for AIDS or cancer.
Midodrine is an alpha-1 agonist. It RAISES blood pressure by constricting blood vessels.
The problem is this drug can cause dangerously high blood pressure when these patients sit or lie down. Save ProAmatine for patients with SEVERE symptoms...those whose lives are considerably impaired by dizziness, weakness, and fainting upon standing.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote